Abstract
AI in pharmacy practices has the potential to revolutionize all aspects of pharmaceutical research as well as to improve the clinical application of pharmaceuticals to prevent, treat, or cure disease. AI, a technology that enables machines to simulate human intelligence, has found applications in pharmaceutical research, drug manufacturing, drug delivery systems, clinical trial optimization, treatment plans, and patient-centered services. The Fourth Industrial Revolution in the Health Sector implemented artificial technologies to perform functions by machines and small robotic systems programmed to do human-like tasks resulting in great potential to transform drug discovery by accelerating the research and development timeline. This technology is being adopted by many pharmaceutical companies to help with the drug discovery and development process, which will enable them to work on a variety of research-oriented projects to improve health facilities and easily cure diseases in the future. This review paper examines the Dual impact of artificial intelligence (AI) in the pharmaceutical sector, analyzing its Potential benefits and associated Challenges. AI technologies, including Machine learning, data analytics, and Natural language processing, have Revolutionized drug discovery, clinical trials Optimization, personalized medicine, and Drug safety monitoring. However, concerns Regarding data privacy, bias, regulatory Compliance, and job displacement Necessitate a comprehensive evaluation of Al’s role in healthcare, this review critically Assesses the utility of Al in pharma while Addressing ethical, regulatory, and socioeconomic implications.